Home Hexagon Bio

Hexagon Bio

In operation
Series B
Targeted Small Molecule Therapy Developer
Basic
Enterprise Profile

Basic Information

Hexagon Bio is a data-driven biotechnology company dedicated to developing targeted small-molecule therapies. Hexagon Bio's proprietary platform combines data science and synthetic biology to discover and design drugs from DNA sequences. Hexagon Bio is mining fungal genomes for inspiration for the next generation of targeted therapies for unmet medical needs.
Hexagon Bio, Inc.
California,United States of America
15~50 people
January 01, 2016
info@hexagonbio.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Pharmaceutical Preparations
Technology
Genetic Engineering Targeted Technology
Concept
Therapeutic Products
Application Scenarios
Chemical Drug Innovative Drugs AI+Pharmaceuticals